chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hand the bit of sore arm; numbness on my rightside; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (hand the bit of sore arm) and HYPOAESTHESIA (numbness on my rightside) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 027CZ1A) for COVID-19 vaccination.     The patient's past medical history included High cholesterol from 2006 to 2021.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021 at 11:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (hand the bit of sore arm) and HYPOAESTHESIA (numbness on my rightside). The patient was treated with CORTISONE for Vaccination adverse reaction, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (hand the bit of sore arm) and HYPOAESTHESIA (numbness on my rightside) had not resolved.            Concomitant medication was not reported   This case was linked to MOD-2021-075184 (Patient Link).
Patient developed "first bite syndrome" after a tetanus shot.  Patient states he had no surgery.  Pain in the bilateral parotid region after the first bite of each meal.  No other neurologic symptoms.  No sequelae, but pain persists and started after the shot.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/19/2022 HX OF UPPER GASTROINTESTINAL BLEED R57.9 SHOCK, UNSPECIFIED 11/19/2022 HX OF UPPER GASTROINTESTINAL BLEED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/19/2022 ATRIAL FIBRILLATION, PAROXYSMAL R57.9 SHOCK, UNSPECIFIED 11/19/2022 ATRIAL FIBRILLATION, PAROXYSMAL J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/19/2022 BENIGN ESOPHAGEAL STRICTURE R57.9 SHOCK, UNSPECIFIED 11/19/2022 BENIGN ESOPHAGEAL STRICTURE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/19/2022 RECTAL PROLAPSE R57.9 SHOCK, UNSPECIFIED 11/19/2022 RECTAL PROLAPSE
Around 7:30pm the night after vaccine, patient was standing in bathroom and complained of abdominal pain and headache. She called for mom and when mom saw patient she looked very pale and lips were white. She then lost consciousness. Mom caught her and carried her to bed. She began to try to arouse her, estimates that she was unconscious for ~1 minute. No seizure like activity or movement of extremities.  Once she came to, mom took to ER for evaluation.
Reporter had a friend die from the covid vaccine.; This is a spontaneous report from a non-contactable consumer.A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Reporter had a friend die from the covid vaccine. Outcome of event was fatal.The patient died on an unspecified date. It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Reporter had a friend die from the covid vaccine.
Vomiting started the day after the vaccine. Patient had decreased appetite. Last stool was the morning after the vaccine was given. Went to the ER 3 days after the vaccine. Was treated with ZOFRAN and released. Oral rehydration protocol was reviewed by my staff and started Monday around noon. The patient tolerated the protocol but was less active, more sleepy and less responsive. Patient returned to the ER. I evaluated him there. We gave him 2 fluid boluses. Repeated his abd x-ray. He had large amounts of dark blood, currant colored on rectal. He was transferred to hospital. His exam was positive for intussusception. He had a barium enema to reduce the telescoping bowel but had a complication of perforation during the procedure. The surgeons then proceeded with laparotomy for reduction of the intussusception, resection of sessile mass in terminal ileum with ileocolic resection with ileostomy creation.
Lower Back Pain; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of   in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M2OA) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID (VIT C) for an unknown indication.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Unknown          No concomitant medications reported. Other treatment includes stretching and massage.
Complained of knee pain beginning 5 hour post-injection. Complained of head, neck, stomach and knee pain 10 hours post-injection. Low-grade fever of 100.2 noted 15 hours post-injection. Child extremely lethargic (lying down, no walking/playing) and sobbing from 12 - 36 hours post-injection, when parents stood child up, child was shaking and refused to walk. Child had to be coaxed to drink and refused food for 48 hours post-injection. Fever spiked to 103.4 degrees 26 hours post-injection (administered Tylenol to control fever). Child consistently complained of neck and knee pain until 48 hours post-injection.
This spontaneous report as received from a registered nurse refers to a 5 year old patient. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On 06-SEP-2016, the patient was vaccinated with improperly stored M-M-R II lot # M004305 (dose, frequency, expiry date were not reported) for prophylaxis. The vaccine was purchased with private funds/insurance. The temporary temperature excursion occurred in the fridge on 01-SEP-2016 however, it was not discovered until 26-SEP-2016. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1609USA013814: US-009507513-1609USA014830: US-009507513-1610USA004339.
Caller is a 54 y/o M reporting that he, his 53 y/o F wife and 84 y/o F all received the Pfizer COVID-19 vaccination and have developed symptoms after vaccination. None have ever had adverse reactions to vaccinations.   A 400. Advised can have injection site pain, fatigue, headache, muscle aches, chills, joint pain, and fever. Swollen lymph nodes and nausea have also been reported. Advised to seek medical attention if experiencing any shortness of breath, throat swelling, weakness, or diffuse body rash. Cough, shortness of breath, runny nose, sore throat, or loss of taste or smell are symptoms of SARS-CoV-2 or another infection and not consistent with post-vaccination symptoms. Advised PC is available as needed. TR
initial side effects chills, achy, fatigue lasting approximately 48 hours. 4/8-4/10/2021  startled awake from sleep with feeling of vomit in throat that was gagging me that I was able to swallow back down. the nauseous wasn't going away so went to bathroom and vomited around 12am Thursday 4/22/2021 for about 15 minutes, woke up with rash on my face and neck
Information has been received from a health care professional, author of a literature article, concerning a 38-year-old woman who underwent a general health examination in 1987, in preparation for starting a job as a nurse. Because she had negative serum rubella titers, she received an MMR II (dose, route and lot number not reported). Soon after the vaccination, she developed nausea and left-sided slowness, weakness, and upper extremity tremor. Over the following months, she was evaluated by several neurologists who also noted rigidity and bradykinesia involving her left side. Brain magnetic resonance imaging (MRI) at the time and at present revealed scattered periventricular and deep T2/FLAIR hyperintensities in the bilateral thalami, internal capsule, and left cerebellar hemisphere, none of which enhance with gadolinium. These hyperintensities had neither enhanced nor changed in configuration on serial MRIs over 20 years, and were believed to be consistent with post-vaccination encephalomyelitis. In the year following her vaccination, her left upper extremity rest tremor worsened and she developed a parkinsonian gait. She was initially treated with amantadine, which helped her rest tremor. Soon afterwards, carbidopa/levodopa (manufacturer unknown) were added which further improved her tremor. Approximately five to seven years after starting carbidopa/levodopa (manufacturer unknown), she experienced wearing-off symptoms with prominent left-sided rigidity (WAES#1202USA03822) for which pramipexole was effective. She expressed interest in Deep brain stimulation (DBS) in 2005, but was not offered surgery due to her diagnosis of secondary parkinsonism. Her best "on" times tended to come in the mornings. During these times she felt loose and could walk with minimal assistance. This allowed her to work in the garden independently, an important aspect of her quality of life. During her "off" times she was completely dependent on her husband for all activities. She never had dyskinesias, hallucinations, depression, or cognitive complaints. Neuropsychological evaluation showed no dementia. Her MDS-UPDRS motor score was 79 off medications and 54 on medications, representing a 32% improvement with dopaminergic therapy. Her medications included carbidopa/levodopa (manufacturer unknown) 25/100, 2 pills given 5 times daily, pramipexole 1.5 mg four times daily, amantadine 100 mg three times daily, entacapone 200 mg three times daily, and oxybutynin 5 mg three times daily. The patient underwent bilateral STN DBS electrode placement followed a month later by implantation of a Kinetra stimulator and had no tremor or wearing-off symptoms once stimulation parameters were optimized. At six month follow-up, MDS-UPDRS motor scores were 63 off-medication/on-stimulation and 44 on-medication/on-stimulation. At one year follow-up, her MDS-UPDRS scores remained stable at 53 off-medication/on-stimulation and 45 on-medication/on-stimulation. LED was reduced by 57% at one year follow up. Additional information has been requested.
On 01/10/2022- she was feeling ill by 2:30 in the afternoon had a fever at about 6:30pm - 101.5. She had a  sore arm, fatigue, fever that day  and the next day.  01/11/2021, early in the evening before bed she felt her bottom lip on the left side was swelling up. It was swollen,  it was the size of a big grape tomato and painful and she was absolutely miserable.  The next morning it progressed to her left jaw line,  swollen gland on her left side and swollen lymph nodes on her left side and her pain was from the bottom of her neck on left side going from her lip to the left side and she was saying that her left ear hurt. She was all swollen . We started giving her Benadryl and the swelling would go down a little bit, after 5 hrs it would wear off and the swelling would continue. The doctor told us to keep her on Benadryl, and  ibuprofen.  By 4 in the afternoon, she was in a lot of pain. I was getting worried. The APRN told us to take her to the ER, that she need to be seen in the emergency Hospital.  01/12/2021- We took her to the ER. They gave her Benadryl and ibuprofen and we waited an 1 1/2 before she was seen . The doctor gave her one dose or oral steroids, dexamethasone.  Originally the APRN, thought it was possibly and allergy, This doctor felt it was an overly strong immune response. Her lip was so swollen, that it actually cracked. She was miserable. The steroids really worked, It helped the swelling go down.  She was a lot more comfortable on the way home and she did not have a fever.  On Thursday and Friday, she was completely exhausted. She was complaining about her lip hurting . She finally left the house on Saturday.  She felt fine to go back to school today, 01/18/2022. She did get considerably better after the steroid.
Itching all over body; Redness; Chills; Arm was sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching all over body), ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm was sore) and CHILLS (Chills) in an 81-year-old female patient who received mRNA-1273 (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic kidney disease stage 4. Concomitant products included TORSEMIDE, ALLOPURINOL, DILTIAZEM, MONTELUKAST, GABAPENTIN, ESCITALOPRAM, PRAVASTATIN, PRAMIPEXOLE, CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]), PARACETAMOL (TYLENOL), VITAMIN D3 and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 08-Mar-2021, the patient experienced PRURITUS (Itching all over body), ERYTHEMA (Redness) and CHILLS (Chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form. At the time of the report, PRURITUS (Itching all over body), ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm was sore) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.       For her symptoms her doctor told her use ice packs.
Pregnant after 1st dose / Planning to get the 2nd one; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant after 1st dose / Planning to get the 2nd one) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 03-Jan-2021 and the estimated date of delivery was 10-Oct-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant after 1st dose / Planning to get the 2nd one). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  first week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant after 1st dose / Planning to get the 2nd one) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment information was provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up received. Vaccine and reporter information updated
Pain at injection site - then shooting pain & burning from site of injection shoulder to neck also muscle spasms. Also: fever; diarrhea.
06/05/2022-  At home PCR test was positive for COVID-19.  I notified my physician and she suggested I begin Vitamin C 3000 mg by mouth every day, D3, 10, 000 IU by mouth every day and Zinc 50 mg by mouth every day.   06/24/2022- Urgent care visit with temperature 103, pulse 120, pulse ox 93% and chest x-ray showing bilateral lower lobe pneumonia.  Began Azithromycin 250 mg 6 tabs by mouth, Prednisone 50 mg by mouth every day x 5 days, Albuterol Sulfate 90 mcg 2 puffs every 6 hours as needed.
Symptoms: Elevated heart rate at rest and with minimal exertion; shortness of breath; light headed/ pre syncope events; increased fatigue Treatment: Increased once daily Bisoprolol Fumarate 10mg dose (POTS treatment) to 5mg in AM and 10 mg in PM for 2 weeks. Increased dose helped symptoms, but when tried to go back to original dose after 2 weeks symptoms returned.  Returned to taking 5mg Am and 10mg PM daily and subsequent attempts to decrease dose since have resulted in incresed symptoms. Currently still taking 5mg AM and 10mg PM.
This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 48 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 34/40 which was not suggestive of malingering (<6). The patient was diagnosed with mild mircosmia (20th percentile). The PEA (phenyl ethyl alcohol) test scores were -5.25 left, -5.75 right and -5.70 bilateral. The Whole-Mouth test identification test score was 73% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore shoulder) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 031M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On an unknown date, the patient experienced ARTHRALGIA (Sore shoulder). At the time of the report, ARTHRALGIA (Sore shoulder) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-369437, MOD-2021-369454 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Oct-2021: Added no new information.
Patient received vaccine on Fri Sept 26 and reported Mon Sept 29 of swelling, redness, warm to the touch and patient had trouble sleeping on it bc it was painful.
5th dose of DTaP administered too soon as patient was up to date with vaccines for age. Extra dose of Prevnar 13 administered.
On 4/30/00, mother noted a single, red lesion behind right ear. Few others were noted during the evening. By 5/1/00, pt's face, scalp and trunk were covered in a red, nonpustular "measles type" rash. Exam, on 5/1/00 at 12:00, had faint and sparse lesions on extremities. Pt with mouth pain, no noted lesions and coryza.
This spontaneous report as received from a Licensed Vocational Nurse refers to an adult patient (exact age not specified). On 01-JUL-2013 the patient was vaccinated with the first dose of RECOMBIVAX HB (dose and lot # not reported). On 30-DEC-2013 the patient was vaccinated with a second dose of RECOMBIVAX HB (dose and lot # not reported). The patient experienced no adverse symptoms. Additional information has been requested.
Adverse effect of other vaccines and biological substances, initial encounter on 2022-09-23.
Information has been received from a physician concerning a female who in November 2007, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. The arm was red and swollen after vaccination. As of the report date, the patient's symptoms persisted. Additional information has been requested.
arthritis onset 14 days p/vax lasting @ least 2 wks; multiple large & small joints affected;
Had to go to hospital. Couldn?t get out of bed. Couldn?t move my arms. Very weak. High temperature 102.2.  My partner called 911
Did not received second dose. Hospitalization 07/28/21-08/03/21. Received Remdesivir 7/29-8/2 and dexamethasone 6 mg IV daily 7/29-8/3
WARM, RED, SWELLING AT INJECTION SITE  PERSISTED FOR 3 WEEKS. NO COMMENT OF  PAIN. ARM; BETTER NOW
Had swelling, redness, & itching in area of arm (left) that she received both vaccines. Was dizzy and nauseous Friday & Saturday and had trouble getting to bathroom due to nausea. Slept for several hours. Still symptomatic on Saturday 1 day after vaccine & went to ER.
105 degree fever, chills, fatigue, pain in injection site that  extended to neck, shoulder, right breast, and right leg and thigh.  Headache.  These symptoms were at there worst for first 48 hours. I am now at day 5 and continue with headache, arm pain and right leg tingling.
Fever started at 12 hrs  after injection and peaked to 104 24 hrs after injection.  Used ice packs and ibuprofen to get it down.  As of today I am still feverish with temp around 100. Chills, fatigue', headache, nausea.  Drank a lot of fluid and rest. Tachycardia.  Pulse was in the 120s all day.
lost parent to Covid; lost parent to Covid; This is a spontaneous report from a non-contactable consumer (daughter). This consumer reported similar events for both parents. This is one of her parents cases. A patient of unspecified age and gender received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The daughter recently lost parent to covid and not sure if this was a fresh or the vaccine side effects. The outcome of event was fatal. The patient died on an unspecified date. It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER_INC-202101440331 same drug and AE., different patient; Reported Cause(s) of Death: lost parent to Covid; lost parent to Covid
mom reported pt c/o pain in lt arm-area was red & swollen & pt had a fever;pain/limitation of ROM/swelling & inflammation persisted;31JAN97 lt deltoid area had an area of induration 7 1/2cm b 10cm red/warm to touch;sore throat & ear p